Psilocybin for the treatment of anorexia nervosa - Nature Medicine

Canada News News

Psilocybin for the treatment of anorexia nervosa - Nature Medicine
Canada Latest News,Canada Headlines
  • 📰 NatureMedicine
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 53%

News & Views: An encouraging phase 1 trial underscores the need for more research into classic psychedelics for treatment of anorexia nervosa, to address the urgent need for effective treatments. StefanEhrlich3 tudresden_de ChariteBerlin

, ten participants with AN of 19.7) received one dose of psilocybin together with psychological support. The treatment was shown to be safe, well tolerated, and acceptable to patients.

Adverse effects were mild and mirrored typical psilocybin-associated symptoms such as transient headache, nausea and fatigue; no serious medical or psychiatric adverse events were reported. Shape concerns significantly decreased at the 1 month follow-up, and four patients had decreases in eating disorder scores at 3 months that qualified them for remission from eating disorder psychopathology.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NatureMedicine /  🏆 451. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study - Nature MedicinePsilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study - Nature MedicinePhase 1 trial results demonstrate that psilocybin in conjunction with psychological support is safe, tolerable and deemed acceptable and therapeutically meaningful by female individuals with anorexia nervosa.ClinicalTrials.gov identifier: NCT04661514
Read more »

Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial - Nature MedicineNeoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial - Nature MedicineIn the NATION-1907 trial, treatment of patients with resectable esophageal squamous cell carcinoma with the anti-PD-L1 agent adebrelimab was safe and showed preliminary overall survival efficacy, with responders exhibiting an immune-enriched tumor microenvironment phenotype at baseline.
Read more »

Israeli Parliament Passes Judicial Overhaul BillIsraeli Parliament Passes Judicial Overhaul BillIsraeli Parliament Passes Judicial Overhaul Bill | Compare reporting by BreitbartNews BBCWorld nytimes
Read more »

Psychedelic psilocybin could treat anorexia in some patients, trial suggestsPsychedelic psilocybin could treat anorexia in some patients, trial suggestsTen patients with anorexia were treated with psilocybin and reported a positive experience, and four experienced remission of their symptoms.
Read more »

UW begins recruitment for psychedelic cancer therapy studyUW begins recruitment for psychedelic cancer therapy studyA psilocybin survey investigates psychedelics affect on anxiety.
Read more »

Commuter alert: SEPTA temporarily closes Penn Medicine Station; alters 3 Regional Rail linesCommuter alert: SEPTA temporarily closes Penn Medicine Station; alters 3 Regional Rail linesDue to a project started this past weekend, SEPTA's Penn Medicine Station is closed and its Media/Wawa, Wilmington/Newark, and Airport lines are impacted.
Read more »



Render Time: 2025-03-01 05:21:14